Evidence map›Paper›PMID 42848231›Full record

ArticleJournal of artificial organs : the official journal of the Japanese Society for Artificial Organs2026

Pre-cannulation ventilation duration and the trajectory of venovenous extracorporeal membrane oxygenation in COVID-19-related acute respiratory distress syndrome: a nationwide competing-risks cohort study.

Takahiro Masuda, Akihiro Hirakawa, Japan ECMOnet for COVID-19

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Takahiro MasudaDepartment of Anesthesiology, Institute of Science Tokyo Hospital, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. tmasicu@tmd.ac.jp.ORCID http://orcid.org/0000-0002-4727-8689
Akihiro HirakawaDepartment of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Japan ECMOnet for COVID-19

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePre-cannulation ventilation duration is often considered in selecting candidates for venovenous extracorporeal membrane oxygenation, but its relationship with the subsequent support trajectory is uncertain. We examined associations with first liberation, death before liberation, and time on support.

methodsWe analyzed a nationwide Japanese registry of patients receiving venovenous extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome. First liberation and death before liberation were treated as competing transitions over 90 days. Cause-specific Cox models were stratified by epidemic period and adjusted for age, sex, and body mass index. Expected time on support was calculated from state-occupancy probabilities.

resultsAmong 1,420 patients, the adjusted hazard ratio for first liberation relative to 0-1 days was 0.87 (95% confidence interval 0.72-1.05) for 2-3 days, 0.65 (0.54-0.78) for 4-7 days, 0.41 (0.32-0.52) for 8-14 days, and 0.58 (0.34-0.98) for at least 15 days. The association was strongest during the first 14 days. Death before liberation, which does not represent overall mortality because follow-up after liberation was short, showed no monotonic gradient below 15 days. Expected time on support was 26.9 days after more than 7 days of ventilation and 18.4 days after 7 days or less.

conclusionsAmong selected recipients, longer pre-cannulation ventilation, particularly 8-14 days, was associated with slower early liberation and longer support. It may inform the anticipated course and resource requirements after cannulation, but does not define a candidacy threshold.

Indexed as

COVID-19Extracorporeal Membrane OxygenationRespiration, ArtificialRespiratory Distress SyndromeAgedCatheterizationCohort StudiesFemaleHumansJapanMaleMiddle AgedRegistriesSARS-CoV-2Time FactorsCompeting risksCOVID-19DecannulationExtracorporeal membrane oxygenationMechanical ventilation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.